Megan Sniecinski Praxis Precision Medicines, Inc. (PRAX) insider trading activity

Megan Sniecinski is Chief Operating Officer of Praxis Precision Medicines, Inc.. Currently has a direct ownership of 28,530 shares of PRAX, which is worth approximately $5.45 Million. The most recent transaction as insider was on Jan 12, 2026, when has been sold 885 shares (Common Stock) at a price of $275.74 per share, resulting in proceeds of $244,029. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.5K

n/a 3M change

n/a 12M change

Total Value Held $5.45 Million

Megan Sniecinski Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 12 2026	SELL Payment of exercise price or tax liability	$244,029 $275.74 p/Share	885 Reduced 3.01%	28,530 Common Stock
Jan 10 2026	SELL Payment of exercise price or tax liability	$313,545 $288.45 p/Share	1,087 Reduced 3.56%	29,415 Common Stock
Jan 08 2026	BUY Grant, award, or other acquisition	-	9,625 Added 23.99%	30,502 Common Stock

Also insider at

BCRX

BIOCRYST PHARMACEUTICALS INC Healthcare

Chief Business Officer